The haemato oncology testing market was valued at USD 4.01 Billion in 2024, driven by the rising prevalence of blood cancers and the growing demand for advanced diagnostic tools across the globe. The market is anticipated to grow at a CAGR of 13.80% during the forecast period of 2025-2034, with the values likely to reach USD 14.61 Billion by 2034.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
13.8%
Value in USD Billion
2025-2034
Haemato Oncology Testing Market Outlook
*this image is indicative*
Haematological malignancies are among the top ten malignant disorders in terms of incidence rate and cause of death in cancer patients. They collectively make up about 9% of all cancer cases diagnosed in a year. Geneticists provide not only diagnostic tests to haemato oncologists, but also key knowledge of cancer genetics that helps the specialists evaluate their patient’s prognosis, select the most appropriate anticancer therapy, and monitor treatment response.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Haemato oncology testing is a test that aids in the diagnosis of blood disease (haematology) and cancer (oncology), further supporting the treatment and prevention of the disease, and providing research into them. Haematology-oncology includes diseases such as iron deficiency anaemia, haemophilia, sickle cell disease, thalassemia, leukaemia, and other organ cancers. The haemato oncology testing industry can be divided based on segments like cancer type, technology, and application.
Market Breakup by Cancer Type
Market Breakup by Technology
Market Breakup by Application
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global haemato oncology testing market is driven by haematological cancer’s increasing global prevalence, increasing awareness of personalized medicines, and increasing collaborations to develop new assays. On the other hand, it is expected that an uncertain reimbursement scenario will restrict the growth of this market during the forecast period in various regions.
The services segment represents the largest proportion of haemato oncology testing. This is mainly due to the growing prevalence and incidence of leukaemia, non-Hodgkin lymphoma, and cancer of myeloma. In addition, the growing awareness of advanced therapies such as personalized medicine also drives this segment’s growth. The growth in the Asia Pacific market is driven primarily by the large patient population, and a growing focus on expanding in this region will drive the industry growth.
The report presents a detailed analysis of the following key players in the global haemato oncology testing market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market was valued at USD 4.01 Billion in 2024.
The market is anticipated to grow at a CAGR of 13.80% during the forecast period of 2025-2034, with the values likely to reach USD 14.61 Billion by 2034.
The market is estimated to witness a healthy growth in the forecast period of 2025-2034 to reach about USD 14.61 Billion by 2034.
The major drivers expected to aid the market growth are the increasing prevalence of haematologic cancer, rising awareness regarding advanced therapies for cancer treatment, preference for personalised medical solutions, improving health care facilities, and growing technological advancements.
The key trends guiding the growth of the market include advancements in diagnostics and testing solutions, growing collaborations and research and development activities, and the development of real time assay kits.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Leukaemia, Lymphoma, and Hodgkin Lymphoma, among others, are the major cancer types in the market.
PCR, IHC, NGS, and cytogenetics, among others, are the significant haemato oncology testing technologies available in the market.
Clinical laboratories, hospitals, and academic and research institutes, among others, are the leading applications of the product in the market.
The key players in the global haemato oncology testing market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Qiagen N.V, Thermo Fisher Scientific Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., and ICON plc, among others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Cancer Type |
|
| Breakup by Technology |
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
